Clinical Trial Update: Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 double-blind study comparing rotigotine to placebo in early-stage idiopathic Parkinson's disease. The study results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: IDIOPATHIC PARKINSON'S DISEASE | Phase 3 | Status: COMPLETED | Results posted: 2015-08-11